{"id":53247,"date":"2022-12-22T08:00:27","date_gmt":"2022-12-22T13:00:27","guid":{"rendered":"https:\/\/wfh.org\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/"},"modified":"2026-03-12T10:00:55","modified_gmt":"2026-03-12T14:00:55","slug":"temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica","status":"publish","type":"post","link":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/","title":{"rendered":"Temas clave se abordaron durante la 5a Mesa redonda de la FMH sobre terapia g\u00e9nica"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"53247\" class=\"elementor elementor-53247 elementor-53068\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e432cae elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e432cae\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f6a4974\" data-id=\"f6a4974\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5b2ff49 elementor-widget elementor-widget-text-editor\" data-id=\"5b2ff49\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>El primer d\u00eda de la <a href=\"https:\/\/wfh.org\/es\/actividades-de-cabildeo\/#gtrt\" target=\"_blank\" rel=\"noopener\">MRTG<\/a> arranc\u00f3 con una actualizaci\u00f3n general sobre el estado de diferentes productos de terapia g\u00e9nica, seguida de una sesi\u00f3n que abord\u00f3 la importancia de comunicar los hallazgos cient\u00edficos de manera imparcial y equilibrada. Las sesiones posteriores se centraron en seguridad, variabilidad y durabilidad de las terapias g\u00e9nicas tanto de factor VIII como de factor IX; perspectivas reglamentarias en Estados Unidos y Europa; y consentimiento informado y toma de decisiones compartidas, inclusive la presentaci\u00f3n de la <a href=\"https:\/\/wfh.org\/es\/article\/disponible-pronto-la-herramienta-de-la-fmh-para-tomar-decisiones-compartidas-en-el-tratamiento-de-la-hemofilia\/\" target=\"_blank\" rel=\"noopener\">Herramienta de la FMH para tomar decisiones compartidas en el tratamiento de la hemofilia<\/a> que se encuentra actualmente en proceso de elaboraci\u00f3n.<\/p>\n<p>El segundo d\u00eda se enfoc\u00f3 en diferentes aspectos de la accesibilidad, y los ponentes abordaron maneras de ampliar la elegibilidad m\u00e1s all\u00e1 de las limitaciones actuales, y alternativas a los virus adenoasociados (VAA), tales como lentivirus, edici\u00f3n gen\u00e9tica, y terapia g\u00e9nica no viral. Las dos sesiones finales giraron en torno al tema de precio y comercializaci\u00f3n de la terapia g\u00e9nica en pa\u00edses de ingresos medios altos, y los desaf\u00edos espec\u00edficos que enfrentan los pa\u00edses de ingresos medios bajos.<\/p>\n<p>La 5<sup>a<\/sup> MRTG de la FMH foment\u00f3 una importante e informativa conversaci\u00f3n entre todas las partes interesadas a medida que continua el di\u00e1logo sobre la terapia g\u00e9nica para la hemofilia. Para obtener m\u00e1s informaci\u00f3n sobre la serie de MRTG de la FMH haga <a href=\"https:\/\/wfh.org\/es\/actividades-de-cabildeo\/#gtrt\" target=\"_blank\" rel=\"noopener\">clic aqu\u00ed<\/a>.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>La 5a Mesa redonda de la Federaci\u00f3n Mundial de Hemofilia (FMH) sobre terapia g\u00e9nica (MRTG) tuvo lugar en Montreal, Canad\u00e1, los d\u00edas 17 y 18 de noviembre de 2022. Esta primera mesa redonda realizada en persona desde hace tres a\u00f1os reuni\u00f3 a representantes de organizaciones nacionales miembros (ONM), defensores de pacientes, profesionales de la salud, encargados de la reglamentaci\u00f3n y representantes de la industria, con el prop\u00f3sito de conversar sobre los avances m\u00e1s recientes en terapia g\u00e9nica para la hemofilia, as\u00ed como sobre los desaf\u00edos y las oportunidades que presenta esta nueva opci\u00f3n terap\u00e9utica.<\/p>\n","protected":false},"author":13,"featured_media":52962,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[169,159],"tags":[],"search-category":[85],"class_list":["post-53247","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events-2","category-gtrt","search-category-article"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Temas clave se abordaron durante la 5a Mesa redonda de la FMH sobre terapia g\u00e9nica | FMH - Federaci\u00f3n Mundial de Hemofilia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Temas clave se abordaron durante la 5a Mesa redonda de la FMH sobre terapia g\u00e9nica\" \/>\n<meta property=\"og:description\" content=\"La 5a Mesa redonda de la Federaci\u00f3n Mundial de Hemofilia (FMH) sobre terapia g\u00e9nica (MRTG) tuvo lugar en Montreal, Canad\u00e1, los d\u00edas 17 y 18 de noviembre de 2022. Esta primera mesa redonda realizada en persona desde hace tres a\u00f1os reuni\u00f3 a representantes de organizaciones nacionales miembros (ONM), defensores de pacientes, profesionales de la salud, encargados de la reglamentaci\u00f3n y representantes de la industria, con el prop\u00f3sito de conversar sobre los avances m\u00e1s recientes en terapia g\u00e9nica para la hemofilia, as\u00ed como sobre los desaf\u00edos y las oportunidades que presenta esta nueva opci\u00f3n terap\u00e9utica.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/\" \/>\n<meta property=\"og:site_name\" content=\"FMH - Federaci\u00f3n Mundial de Hemofilia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/wfhemophilia\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-22T13:00:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-12T14:00:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/GTRT-recap-header.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mitch Semienchuk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mitch Semienchuk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/\"},\"author\":{\"name\":\"Mitch Semienchuk\",\"@id\":\"https:\/\/wfh.org\/es\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b\"},\"headline\":\"Temas clave se abordaron durante la 5a Mesa redonda de la FMH sobre terapia g\u00e9nica\",\"datePublished\":\"2022-12-22T13:00:27+00:00\",\"dateModified\":\"2026-03-12T14:00:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/\"},\"wordCount\":265,\"publisher\":{\"@id\":\"https:\/\/wfh.org\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/GTRT-recap-header.jpg\",\"articleSection\":[\"Events\",\"WFH Gene Therapy Round Table (GTRT)\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/\",\"url\":\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/\",\"name\":\"Temas clave se abordaron durante la 5a Mesa redonda de la FMH sobre terapia g\u00e9nica | FMH - Federaci\u00f3n Mundial de Hemofilia\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/GTRT-recap-header.jpg\",\"datePublished\":\"2022-12-22T13:00:27+00:00\",\"dateModified\":\"2026-03-12T14:00:55+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/#primaryimage\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/GTRT-recap-header.jpg\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/GTRT-recap-header.jpg\",\"width\":1200,\"height\":627},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wfh.org\/es\/#website\",\"url\":\"https:\/\/wfh.org\/es\/\",\"name\":\"FMH - Federaci\u00f3n Mundial de Hemofilia\",\"description\":\"WFH - World Federation of Hemophilia\",\"publisher\":{\"@id\":\"https:\/\/wfh.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wfh.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wfh.org\/es\/#organization\",\"name\":\"World Federation of Hemophilia\",\"url\":\"https:\/\/wfh.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/wfh.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"width\":210,\"height\":63,\"caption\":\"World Federation of Hemophilia\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/wfhemophilia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/wfh.org\/es\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b\",\"name\":\"Mitch Semienchuk\",\"sameAs\":[\"analytics\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Temas clave se abordaron durante la 5a Mesa redonda de la FMH sobre terapia g\u00e9nica | FMH - Federaci\u00f3n Mundial de Hemofilia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/","og_locale":"es_ES","og_type":"article","og_title":"Temas clave se abordaron durante la 5a Mesa redonda de la FMH sobre terapia g\u00e9nica","og_description":"La 5a Mesa redonda de la Federaci\u00f3n Mundial de Hemofilia (FMH) sobre terapia g\u00e9nica (MRTG) tuvo lugar en Montreal, Canad\u00e1, los d\u00edas 17 y 18 de noviembre de 2022. Esta primera mesa redonda realizada en persona desde hace tres a\u00f1os reuni\u00f3 a representantes de organizaciones nacionales miembros (ONM), defensores de pacientes, profesionales de la salud, encargados de la reglamentaci\u00f3n y representantes de la industria, con el prop\u00f3sito de conversar sobre los avances m\u00e1s recientes en terapia g\u00e9nica para la hemofilia, as\u00ed como sobre los desaf\u00edos y las oportunidades que presenta esta nueva opci\u00f3n terap\u00e9utica.","og_url":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/","og_site_name":"FMH - Federaci\u00f3n Mundial de Hemofilia","article_publisher":"https:\/\/www.facebook.com\/wfhemophilia\/","article_published_time":"2022-12-22T13:00:27+00:00","article_modified_time":"2026-03-12T14:00:55+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/GTRT-recap-header.jpg","type":"image\/jpeg"}],"author":"Mitch Semienchuk","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Mitch Semienchuk","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/#article","isPartOf":{"@id":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/"},"author":{"name":"Mitch Semienchuk","@id":"https:\/\/wfh.org\/es\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b"},"headline":"Temas clave se abordaron durante la 5a Mesa redonda de la FMH sobre terapia g\u00e9nica","datePublished":"2022-12-22T13:00:27+00:00","dateModified":"2026-03-12T14:00:55+00:00","mainEntityOfPage":{"@id":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/"},"wordCount":265,"publisher":{"@id":"https:\/\/wfh.org\/es\/#organization"},"image":{"@id":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/GTRT-recap-header.jpg","articleSection":["Events","WFH Gene Therapy Round Table (GTRT)"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/","url":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/","name":"Temas clave se abordaron durante la 5a Mesa redonda de la FMH sobre terapia g\u00e9nica | FMH - Federaci\u00f3n Mundial de Hemofilia","isPartOf":{"@id":"https:\/\/wfh.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/#primaryimage"},"image":{"@id":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/GTRT-recap-header.jpg","datePublished":"2022-12-22T13:00:27+00:00","dateModified":"2026-03-12T14:00:55+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/wfh.org\/es\/article\/temas-clave-se-abordaron-durante-la-5a-mesa-redonda-de-la-fmh-sobre-terapia-genica\/#primaryimage","url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/GTRT-recap-header.jpg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/12\/GTRT-recap-header.jpg","width":1200,"height":627},{"@type":"WebSite","@id":"https:\/\/wfh.org\/es\/#website","url":"https:\/\/wfh.org\/es\/","name":"FMH - Federaci\u00f3n Mundial de Hemofilia","description":"WFH - World Federation of Hemophilia","publisher":{"@id":"https:\/\/wfh.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wfh.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/wfh.org\/es\/#organization","name":"World Federation of Hemophilia","url":"https:\/\/wfh.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/wfh.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","width":210,"height":63,"caption":"World Federation of Hemophilia"},"image":{"@id":"https:\/\/wfh.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/wfhemophilia\/"]},{"@type":"Person","@id":"https:\/\/wfh.org\/es\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b","name":"Mitch Semienchuk","sameAs":["analytics"]}]}},"_links":{"self":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/posts\/53247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/comments?post=53247"}],"version-history":[{"count":1,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/posts\/53247\/revisions"}],"predecessor-version":[{"id":173299,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/posts\/53247\/revisions\/173299"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/media\/52962"}],"wp:attachment":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/media?parent=53247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/categories?post=53247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/tags?post=53247"},{"taxonomy":"search-category","embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/search-category?post=53247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}